Avricore Health (AVCRF) Cash & Current Investments (2009 - 2026)
Avricore Health (AVCRF) posted quarterly Cash & Current Investments of $153352.7 for Q1 2026, down 82.81% year-over-year from $891847.5 in Q1 2025, and down 10.11% quarter-over-quarter from $170607.7 in Q4 2025.
Avricore Health (AVCRF) Cash & Current Investments (2009 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported Cash & Current Investments for 18 consecutive years, with $153352.7 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 82.81% year-over-year to $153352.7; the TTM figure through Jun 2026 stood at $25628.4 (down 95.9% YoY), while the FY2025 annual figure was $170283.0, down 79.59% from the prior year.
- Cash & Current Investments fell to $153352.7 in Q1 2026 per AVCRF's latest filing, from $170607.7 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $1.7 million in Q1 2022 and bottomed at $153352.7 in Q1 2026.
- Historically, Cash & Current Investments has averaged $599269.6 across 5 years, with a median of $440845.7 in 2024.
- Annual changes were most pronounced in 2024 — Cash & Current Investments surged 288.5% — and 2026, when it tumbled 82.81%.
- Avricore Health's Cash & Current Investments stood at $464511.1 in 2022, then tumbled by 54.68% to $210496.6 in 2023, then soared by 288.5% to $817780.3 in 2024, then slumped by 79.14% to $170607.7 in 2025, then retreated by 10.11% to $153352.7 in 2026.
- Business Quant data shows AVCRF's Cash & Current Investments at $153352.7 in Q1 2026, $170607.7 in Q4 2025, and $393656.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 196.93 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 2.08 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.10 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.17 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 626.00 Mn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 153,352.69 |
| Dec 31, 2025 | 170,607.73 |
| Sep 30, 2025 | 393,655.97 |
| Jun 30, 2025 | 624,418.44 |
| Mar 31, 2025 | 891,847.50 |
| Dec 31, 2024 | 817,780.33 |
| Sep 30, 2024 | 581,363.35 |
| Jun 30, 2024 | 416,643.56 |
| Mar 31, 2024 | 440,845.67 |
| Dec 31, 2023 | 210,496.58 |
| Sep 30, 2023 | 298,022.35 |
| Jun 30, 2023 | 359,102.28 |
| Mar 31, 2023 | 386,681.45 |
| Dec 31, 2022 | 464,511.09 |
| Sep 30, 2022 | 904,092.73 |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Jun 30, 2021 | 2.12 Mn |